Effects on human transcriptome of mutated BRCA1 BRCT domain: A microarray study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects on human transcriptome of mutated BRCA1 BRCT domain: A microarray study ; volume:12 ; number:1 ; day:30 ; month:5 ; year:2012 ; pages:1-11 ; date:12.2012
BMC cancer ; 12, Heft 1 (30.5.2012), 1-11, 12.2012
- Urheber
-
Iofrida, Caterina
- Beteiligte Personen und Organisationen
-
Melissari, Erika
Mariotti, Veronica
Guglielmi, Chiara
Guidugli, Lucia
Caligo, Maria Adelaide
Pellegrini, Silvia
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-12-207
- URN
-
urn:nbn:de:1111-201603041832
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Iofrida, Caterina
- Melissari, Erika
- Mariotti, Veronica
- Guglielmi, Chiara
- Guidugli, Lucia
- Caligo, Maria Adelaide
- Pellegrini, Silvia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers
Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines
PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy
Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families
Interactions of BRCA1-mutated Breast Cancer Cell Lines with Adipose-derived Stromal Cells (ADSCs)
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
Generation of a non-small cell lung cancer transcriptome microarray
RNA-seq and microarray complement each other in transcriptome profiling
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers
Dynamic disequilibrium-based pathogenicity model in mutated pyrin’s B30.2 domain—Casp1/p20 complex
Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain
Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers
Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines
PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy
Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families
Interactions of BRCA1-mutated Breast Cancer Cell Lines with Adipose-derived Stromal Cells (ADSCs)
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
Generation of a non-small cell lung cancer transcriptome microarray
RNA-seq and microarray complement each other in transcriptome profiling
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers
Dynamic disequilibrium-based pathogenicity model in mutated pyrin’s B30.2 domain—Casp1/p20 complex
Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain
Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers
Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines
PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy
Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families
Interactions of BRCA1-mutated Breast Cancer Cell Lines with Adipose-derived Stromal Cells (ADSCs)
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
Generation of a non-small cell lung cancer transcriptome microarray
RNA-seq and microarray complement each other in transcriptome profiling
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers
Dynamic disequilibrium-based pathogenicity model in mutated pyrin’s B30.2 domain—Casp1/p20 complex